![Hormonsubstitution efter salpingo-ooforektomi hos BRCA1/2-mutationsbærere øger ikke risikoen for brystkræft | Ugeskriftet.dk Hormonsubstitution efter salpingo-ooforektomi hos BRCA1/2-mutationsbærere øger ikke risikoen for brystkræft | Ugeskriftet.dk](https://ugeskriftet.dk/_next/image?url=https%3A%2F%2Fcontent.ugeskriftet.dk%2Fsites%2Fdefault%2Ffiles%2Fscientific_article%2F2014-09%2F0313018601_0.jpg&w=3840&q=75)
Hormonsubstitution efter salpingo-ooforektomi hos BRCA1/2-mutationsbærere øger ikke risikoen for brystkræft | Ugeskriftet.dk
![PDF) The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial PDF) The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial](https://i1.rgstatic.net/publication/339115955_The_effect_of_assessing_genetic_risk_of_prostate_cancer_on_the_use_of_PSA_tests_in_primary_care_A_cluster_randomized_controlled_trial/links/5e3ebacc458515072d8a7f27/largepreview.png)
PDF) The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
Bilag til Medicinrådets anbefaling vedrørende olaparib til behandling af BRCA-muteret metastatisk kastrationsresistent prostat
![PDF) Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA PDF) Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA](https://i1.rgstatic.net/publication/328671850_Genome-wide_associations_for_benign_prostatic_hyperplasia_reveal_a_genetic_correlation_with_serum_levels_of_PSA/links/5fb42cec92851cf24cdbec2d/largepreview.png)